Nurse Practitioner, Family · Dade City, FL
NPI
1457689275
Since 2009
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
13417 US Highway 301, Suite D
Dade City, FL, 33525
Phone (352) 567-8640
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
1,309 services
Medicare patients, 2024
162
Average age 76
Drug cost, 2024
$528K
7,528 prescriptions
Company payments, 2025
$479
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danielle Williamson was code 99214 (office e&m - established), 370 times for 148 patients. In total Danielle Williamson billed 1,309 services in 38 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 370 | 148 | $72.79 | $27K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 94 | 94 | $106.82 | $10K |
| 99497 Care Management/Coordination | Office | 94 | 94 | $67.23 | $6,319 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 83 | 83 | $15.28 | $1,268 |
| 99213 Office E&M - Established | Office | 74 | 50 | $48.01 | $3,553 |
| 81002 Clinical Chemistry | Office | 42 | 29 | $3.41 | $143 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 27 | 23 | $66.02 | $1,783 |
| 96372 Injection Administration | Office | 20 | 14 | $8.82 | $176 |
By year: 2022 $66K for 1,201 services; 2023 $75K for 1,246 services; 2024 $55K for 1,309 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 42 | 29 | $3.41 | $143 |
| 87428 Infectious Agent Detection by DNA/RNA | 27 | 23 | $66.02 | $1,783 |
Medicare prescription drug claims, 2024
In 2024, the drug Danielle Williamson prescribed most often to Medicare patients was Atorvastatin Calcium, with 407 prescriptions and refills. In total Danielle Williamson wrote 7,528 Medicare prescriptions that cost $528K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 407 | 1,188 | 115 | $2,833 |
| Rosuvastatin Calcium Generic | 360 | 1,063 | 112 | $3,355 |
| Levothyroxine Sodium Generic | 292 | 831 | 78 | $2,402 |
| Lisinopril Generic | 290 | 834 | 81 | $1,211 |
| Amlodipine Besylate Generic | 275 | 708 | 75 | $1,029 |
| Omeprazole Generic | 185 | 543 | 64 | $2,236 |
| Tramadol Hcl Generic | 175 | 175 | 54 | $1,220 |
| Metformin Hcl Generic | 148 | 428 | 44 | $851 |
| Alprazolam Generic | 144 | 164 | 55 | $524 |
| Furosemide Generic | 142 | 370 | 59 | $431 |
| Losartan Potassium Generic | 140 | 402 | 45 | $1,163 |
| Gabapentin Generic | 128 | 343 | 40 | $1,640 |
| Duloxetine Hcl Generic | 126 | 350 | 38 | $1,671 |
| Prednisone Generic | 120 | 132 | 94 | $271 |
| Citalopram Hbr Citalopram Hydrobromide | 117 | 316 | 40 | $690 |
Brand drugs: 895 claims; generic drugs: 6,531 claims; opioid claims: 188.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danielle Williamson $479 ($479 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $120.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 6 | $120 |
| GlaxoSmithKline, LLC. GSK | 3 | $62.03 |
| Amgen Inc. AMGN | 3 | $54.05 |
| Exact Sciences Corporation EXAS | 3 | $50.11 |
| Merz North America, Inc. | 1 | $49.95 |
| Merck Sharp & Dohme LLC MRK | 1 | $27.78 |
| Boston Scientific Corporation BSX | 1 | $25.25 |
| Pfizer Inc. PFE | 1 | $19.68 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $19.4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.